思创医惠
(300078)
| 流通市值：42.98亿 | | | 总市值：43.15亿 |
| 流通股本：11.13亿 | | | 总股本：11.18亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 409,267,469.05 | 690,765,562.41 | 564,563,042.63 | 396,895,157.25 |
| 营业收入 | 409,267,469.05 | 690,765,562.41 | 564,563,042.63 | 396,895,157.25 |
| 利息收入 | - | 0 | - | - |
| 已赚保费 | - | 0 | - | - |
| 手续费及佣金收入 | - | 0 | - | - |
| 二、营业总成本 | 447,224,428.22 | 975,008,764.36 | 747,741,398.44 | 530,944,228.1 |
| 营业成本 | 386,574,632.4 | 606,939,067.99 | 471,373,535.14 | 335,860,863.4 |
| 利息支出 | - | 0 | - | - |
| 手续费及佣金支出 | - | 0 | - | - |
| 退保金 | - | 0 | - | - |
| 赔付支出净额 | - | 0 | - | - |
| 提取保险合同准备金净额 | - | 0 | - | - |
| 保单红利支出 | - | 0 | - | - |
| 分保费用 | - | 0 | - | - |
| 税金及附加 | 1,690,757.37 | 18,411,615.28 | 14,958,529.25 | 4,542,938.14 |
| 销售费用 | 17,729,203.28 | 79,365,973.16 | 52,290,919.15 | 48,660,842.26 |
| 管理费用 | 21,790,094.5 | 115,819,883.56 | 82,581,715.07 | 45,768,251.89 |
| 研发费用 | 17,324,427.07 | 101,744,405.18 | 86,530,617.16 | 66,864,202.07 |
| 财务费用 | 2,115,313.6 | 52,727,819.19 | 40,006,082.67 | 29,247,130.34 |
| 其中:利息费用 | 3,859,056.8 | 57,237,677.6 | 46,822,650.08 | 34,038,652.73 |
| 其中:利息收入 | -411,277.33 | 3,997,198.02 | -3,375,849.8 | -2,749,816.37 |
| 加:公允价值变动收益 | -1,327,669.66 | -14,330,838.9 | 168,315 | 168,315 |
| 加:投资收益 | 1,530,207.91 | -1,139,469.78 | -1,229,128.03 | -2,438,636.97 |
| 净敞口套期收益 | - | 0 | - | - |
| 汇兑收益 | - | 0 | - | - |
| 资产处置收益 | 7,794,790.23 | -71,126.43 | -141,973.69 | -80,804.04 |
| 资产减值损失(新) | 213,728.83 | -114,980,759.14 | -60,761,811.29 | -59,473,641.62 |
| 信用减值损失(新) | 7,962,696.19 | -39,835,108.02 | -37,260,278.58 | -23,174,779.73 |
| 其他收益 | 2,041,789.34 | 2,412,297.98 | -880,360.81 | -3,864,045.1 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -19,741,416.33 | -452,188,206.24 | -283,283,593.21 | -222,912,663.31 |
| 加:营业外收入 | 1,537,594.73 | 1,363,512.52 | 918,847.89 | 351,944.22 |
| 减:营业外支出 | 449,763.41 | 50,606,445.37 | 487,299.63 | 441,742.63 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -18,653,585.01 | -501,431,139.09 | -282,852,044.95 | -223,002,461.72 |
| 减:所得税费用 | 782,527.59 | 2,661,500.38 | 2,866,789.49 | 2,667,338.08 |
| 六、净利润 | -19,436,112.6 | -504,092,639.47 | -285,718,834.44 | -225,669,799.8 |
| 持续经营净利润 | -19,436,112.6 | -504,067,745.53 | -285,718,834.44 | -225,669,799.8 |
| 终止经营净利润 | - | -24,893.94 | - | - |
| 归属于母公司股东的净利润 | -19,559,000.77 | -501,509,765.24 | -283,640,006.17 | -222,844,191.26 |
| 少数股东损益 | 122,888.17 | -2,582,874.23 | -2,078,828.27 | -2,825,608.54 |
| (一)基本每股收益 | -0.02 | -0.53 | -0.31 | -0.25 |
| (二)稀释每股收益 | -0.02 | -0.53 | -0.31 | -0.25 |
| 八、其他综合收益 | -4,714,745.23 | -5,502,722.37 | -3,120,519.31 | -894,702.86 |
| 归属于母公司股东的其他综合收益 | -5,204,534.34 | -4,121,490.45 | -3,143,007.24 | -828,834.68 |
| 九、综合收益总额 | -24,150,857.83 | -509,595,361.84 | -288,839,353.75 | -226,564,502.66 |
| 归属于母公司股东的综合收益总额 | -24,763,535.11 | -505,631,255.69 | -286,783,013.41 | -223,673,025.94 |
| 归属于少数股东的综合收益总额 | 612,677.28 | -3,964,106.15 | -2,056,340.34 | -2,891,476.72 |
| 公告日期 | 2025-04-30 | 2025-04-30 | 2024-10-30 | 2024-08-28 |
| 审计意见(境内) | | 保留意见 | | |